Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review

Nenhuma Miniatura disponível
Citações na Scopus
4
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCI LTD
Autores
MUHSEN, Ibrahim N.
GALEANO, Sebastian
NIEDERWIESER, Dietger
KOH, Mickey B. C.
LJUNGMAN, Per
KHARFAN-DABAJA, Mohamed A.
CAMARA, Rafael de la
KODERA, Yoshihisa
SZER, Jeff
Citação
LANCET HAEMATOLOGY, v.10, n.4, p.E295-E305, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
There is a scarcity of data on endemic and regionally limited fungal and parasitic infections in recipients of haematopoietic stem-cell transplantation (HSCT) outside western Europe and North America. This Worldwide Network for Blood and Marrow Transplantation (WBMT) Review is one of two papers aiming to provide guidance to transplantation centres worldwide regarding prevention, diagnosis, and treatment based on the currently available evidence and expert opinion. These recommendations were created and reviewed by physicians with expertise in HSCT or infectious disease, representing several infectious disease and HSCT groups and societies. In this paper, we review the literature on several endemic and regionally limited parasitic and fungal infections, some of which are listed as neglected tropical diseases by WHO, including visceral leishmaniasis, Chagas disease, strongyloidiasis, malaria, schistosomiasis, histoplasmosis, blastomycosis, and coccidioidomycosis.
Palavras-chave
Referências
  1. Abdelkefi Abderrahman, 2004, Hematol J, V5, P449, DOI 10.1038/sj.thj.6200531
  2. Agrawal V, 2020, CASE REP HEMATOL, V2020, DOI 10.1155/2020/8124137
  3. Alpern JD, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12638
  4. Altclas J, 2005, BONE MARROW TRANSPL, V36, P123, DOI 10.1038/sj.bmt.1705006
  5. Angheben A, 2012, BLOOD TRANSFUS-ITALY, V10, P542, DOI 10.2450/2012.0015-12
  6. Aronson N, 2016, CLIN INFECT DIS, V63, pE202, DOI 10.1093/cid/ciw670
  7. Ashraf N, 2020, MYCOPATHOLOGIA, V185, P843, DOI 10.1007/s11046-020-00431-2
  8. Buonfrate D, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9060468
  9. Castillo CG, 2016, INFECT DIS CLIN N AM, V30, P247, DOI 10.1016/j.idc.2015.10.002
  10. Chapman SW, 2008, CLIN INFECT DIS, V46, P1801, DOI 10.1086/588300
  11. Crum NF, 2022, INFECT DIS THER, V11, P713, DOI 10.1007/s40121-022-00606-y
  12. Drexler B, 2014, BLOOD, V124, P678, DOI 10.1182/blood-2014-05-576769
  13. Fores R, 2007, BONE MARROW TRANSPL, V39, P127, DOI 10.1038/sj.bmt.1705551
  14. Fukushige M, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009189
  15. Gajurel K, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.13087
  16. Gajurel K, 2017, CLIN TRANSPLANT, V31, DOI 10.1111/ctr.12867
  17. Galeano S, 2021, CURR OPIN INFECT DIS, V34, P323, DOI 10.1097/QCO.0000000000000741
  18. Galgiani JN, 2016, CLIN INFECT DIS, V63, pE112, DOI 10.1093/cid/ciw360
  19. Glenn TJ, 2005, MED MYCOL, V43, P705, DOI 10.1080/13693780500147840
  20. Guiang KMU, 2013, TRANSPL INFECT DIS, V15, pE264, DOI 10.1111/tid.12157
  21. Gupta S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-87
  22. Inoue J, 2010, REV INST MED TROP SP, V52, P281, DOI 10.1590/S0036-46652010000500012
  23. Iori AP, 2014, TRANSPL INFECT DIS, V16, P625, DOI 10.1111/tid.12239
  24. Jarque I, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.035
  25. Jones O, 2009, TRANSPL INFECT DIS, V11, P281, DOI 10.1111/j.1399-3062.2009.00381.x
  26. Kauffman CA, 2014, TRANSPL INFECT DIS, V16, P213, DOI 10.1111/tid.12186
  27. Komitopoulou A, 2014, TRANSPL INFECT DIS, V16, P1012, DOI 10.1111/tid.12316
  28. Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263
  29. Krolewiecki A, 2019, INFECT DIS CLIN N AM, V33, P135, DOI 10.1016/j.idc.2018.10.006
  30. Ladeb S, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12887
  31. Linder KA, 2016, INFECT DIS CLIN PRAC, V24, pE71, DOI 10.1097/IPC.0000000000000444
  32. Machado Clarisse M., 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P321
  33. Machado CM, 2009, REV INST MED TROP SP, V51, P309, DOI 10.1590/S0036-46652009000600002
  34. Mahmoud HK, 1996, BONE MARROW TRANSPL, V17, P401
  35. Mann S, 2021, CURR TROP MED REP, V8, P121, DOI 10.1007/s40475-021-00232-7
  36. Martinez-Losada C, 2013, BONE MARROW TRANSPL, V48, P614, DOI 10.1038/bmt.2012.190
  37. McBride JA, 2017, CLIN CHEST MED, V38, P435, DOI 10.1016/j.ccm.2017.04.006
  38. Mejia R, 2012, TRANSFUSION, V52, P2677, DOI 10.1111/j.1537-2995.2012.03673.x
  39. Mendoza N, 2015, TRANSPL INFECT DIS, V17, P380, DOI 10.1111/tid.12372
  40. Multani A, 2019, BLOOD ADV, V3, P3602, DOI 10.1182/bloodadvances.2019000634
  41. Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846
  42. Nucci M, 2004, CLIN INFECT DIS, V38, P1237, DOI 10.1086/383319
  43. Nucci M, 2013, CLIN MICROBIOL INFEC, V19, P745, DOI 10.1111/1469-0691.12002
  44. Orlent H, 2003, BONE MARROW TRANSPL, V32, P115, DOI 10.1038/sj.bmt.1704104
  45. Pagano L, 2007, CLIN INFECT DIS, V45, P1161, DOI 10.1086/522189
  46. Pan American Health Organization WHO, 2019, GUID DIAGN TREATM CH
  47. PAPPAS PG, 1993, MEDICINE, V72, P311, DOI 10.1097/00005792-199309000-00003
  48. Peixoto D, 2019, INFECT DIS CLIN N AM, V33, P567, DOI 10.1016/j.idc.2019.02.009
  49. Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4
  50. PETERSON MW, 1987, THORAX, V42, P698, DOI 10.1136/thx.42.9.698
  51. Pinazo MJ, 2011, TRANSPLANT REV-ORLAN, V25, P91, DOI 10.1016/j.trre.2010.12.002
  52. Qazilbash MH, 2006, BONE MARROW TRANSPL, V38, P393, DOI 10.1038/sj.bmt.1705448
  53. RILEY DK, 1993, TRANSPLANTATION, V56, P1531
  54. Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1
  55. Saling CF, 2021, J FUNGI, V7, DOI 10.3390/jof7050339
  56. Sirvent-von Bueltzingsloewen A, 2004, BONE MARROW TRANSPL, V33, P667, DOI 10.1038/sj.bmt.1704396
  57. Steiner B, 2002, CLIN INFECT DIS, V34, P1280, DOI 10.1086/339753
  58. Tomblyn M, 2009, BIOL BLOOD MARROW TR, V15, P1143, DOI 10.1016/j.bbmt.2009.06.019
  59. Torres HA, 2002, MEDICINE, V81, P201, DOI 10.1097/00005792-200205000-00004
  60. Toscanini MA, 2021, APPL MICROBIOL BIOT, V105, P1837, DOI 10.1007/s00253-021-11170-9
  61. US Centers for Disease Control and Prevention, MALARIA
  62. Vail G M, 2002, Transpl Infect Dis, V4, P148, DOI 10.1034/j.1399-3062.2002.01016.x
  63. Vasquez-Rios George, 2019, J Parasit Dis, V43, P167, DOI 10.1007/s12639-019-01090-x
  64. VILLALBA R, 1992, CLIN INFECT DIS, V14, P594, DOI 10.1093/clinids/14.2.594
  65. Villeneuve L, 1999, ANN TROP MED PARASIT, V93, P533, DOI 10.1080/00034989958285
  66. Viola GM, 2016, BIOL BLOOD MARROW TR, V22, pS180, DOI 10.1016/j.bbmt.2015.11.553
  67. Wheat LJ, 2007, CLIN INFECT DIS, V45, P807, DOI 10.1086/521259
  68. WHO, NEGLECTED TROPICAL D
  69. WHO, 2021, SCHISTOSOMIASIS
  70. WINSTON DJ, 1979, MEDICINE, V58, P1, DOI 10.1097/00005792-197901000-00001
  71. Wirk B, 2009, TRANSPL INFECT DIS, V11, P143, DOI 10.1111/j.1399-3062.2008.00360.x
  72. Woo PCY, 2005, BONE MARROW TRANSPL, V35, P831, DOI 10.1038/sj.bmt.1704895
  73. World Health Organization, 2021, WORLD REP HEAR
  74. Yalcin A, 1999, Turk J Haematol, V16, P181
  75. Yong A M Y, 2017, Indian Dermatol Online J, V8, P192, DOI 10.4103/idoj.IDOJ_92_16